![Michael Chao](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Michael Chao
Director/Board Member at BioAnalytix, Inc.
Profile
Michael Chao has worked as a Director at BioAnalytix, Inc. and Ansun Biopharma, Inc.
Michael Chao active positions
Companies | Position | Start |
---|---|---|
BioAnalytix, Inc.
![]() BioAnalytix, Inc. Information Technology ServicesTechnology Services BioAnalytix, Inc. develops and applies advanced analytic technologies. It offers advanced analytics, biologic therapeutics, mass spec, drug development and biopharma technologies. The company was founded by Barry L. Karger and Kirtland G. Poss in 2012 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Ansun Biopharma, Inc.
![]() Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
BioAnalytix, Inc.
![]() BioAnalytix, Inc. Information Technology ServicesTechnology Services BioAnalytix, Inc. develops and applies advanced analytic technologies. It offers advanced analytics, biologic therapeutics, mass spec, drug development and biopharma technologies. The company was founded by Barry L. Karger and Kirtland G. Poss in 2012 and is headquartered in Cambridge, MA. | Technology Services |
Ansun Biopharma, Inc.
![]() Ansun Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Ansun Biopharma, Inc. manufactures pharmaceutical products. Its products include Fludase, a drug candidate for the prophylaxis and treatment of respiratory infections caused by various types of influenza virus, including the types of virus that may cause a potential influenza pandemic, as well as various types of parainfluenza virus. The company was founded by Nancy Chang on August 9, 2012 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Michael Chao